The New Eurofarma Factory in Minas Gerais Will Contribute to the Company’s Socio-Environmental Development, as Well as Generate Jobs
The new factory of Eurofarma will count on investments of up to R$ 1.8 billion. The new unit is being developed in Montes Claros, northern Minas Gerais, and it is possible that it will be inaugurated in phases, with the first one expected at the beginning of 2024. The information comes from the website Panorama Farmacêutico.
The new factory in Minas Gerais was redesigned by Eurofarma after a meeting with CODEMA
Discover the Project in Panoramic View
Eurofarma has advanced in the development of the project for the construction of the new factory in Minas Gerais during a regular meeting of the Municipal Council for the Defense and Conservation of the Environment (CODEMA) this current month of July.
-
Santa Catarina invests R$ 1 billion against the risk of El Niño, accelerates work on dams, cleans rivers, delivers 641 bridges and 126 water trucks, and prepares 295 municipalities for heavy rains, floods, and landslides still in 2026.
-
Building a 95-square-meter house in 2026 can start at around R$ 185,000 at the reference base and exceed R$ 330,000 in high standard, but the final cost depends on the land, finishing, fees, and the region, with the South of the country being among the most expensive in Brazil.
-
A small church built in 7 weeks in 1961 stands surrounded by skyscrapers in Balneário Camboriú, the city with the most expensive square meter in Brazil, accommodating only 60 people and defying decades of verticalization and luxury on the coast of Santa Catarina.
-
Satellite images analyzed by Reuters reveal that China is building a vast network of over 80 launch platforms, bunkers, and communication centers in the Xinjiang desert near its nuclear silos, in an effort that analysts say aims to ensure the capability to retaliate in the event of an attack.
During the meeting, the representative of the companies responsible for providing the construction services for Eurofarma’s factory in Minas Gerais presented data to the public regarding the structure of the new Eurofarma factory and also showed the company’s socio-environmental initiatives.
According to environmental analyst Naira Araújo and engineer Guilherme Caldeira, Eurofarma is acquiring just over 200,000 square meters of land to increase its investments.
Eurofarma Factory in Minas Gerais Will Produce from Antibiotics to Hormonal Medications
The new Eurofarma factory will occupy a built area of approximately 280,000 square meters in the new Industrial District of Montes Claros, Minas Gerais, on the Production Road. The company aims to generate about 600 direct jobs and 1,500 indirect jobs with this endeavor.
The main goal of the Eurofarma factory will be to enhance the development of antibiotics, such as amoxicillin and benzathine penicillin, as well as to produce solid and hormonal medications, including Selene, Tamisa, and Testosterone.
The new Eurofarma factory in Minas Gerais will serve Brazil and also countries in Latin America where the company operates. Eurofarma maintains its operations in Argentina, Bolivia, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, and Venezuela, as well as having a presence in Central American markets such as Costa Rica, Panama, and the Dominican Republic.
Eurofarma in Brazil and Around the World
Eurofarma is a multinational pharmaceutical company with 100% Brazilian capital, headquartered in São Paulo. In Brazil alone, it offers over 430 products, more than 1,000 presentations, and serves 30 medical specialties, covering over 200 therapeutic classes, which represent 80% of the total sector.
The company is present in more than 20 countries, has a 50-year history, and aims to make healthcare accessible so that all people can live longer and better. With just over 8,100 professionals, Eurofarma operates in all major pharmacy segments and holds the title of leader in medical prescriptions in Brazil. The company is guided by solid values and believes that businesses have an important role in transforming society. Eurofarma understands that diversity and inclusion are the key elements in its growth story and to increasingly make the company global.
Eurofarma seeks to increasingly include a plurality of profiles, genders, races, orientations, and identities in its workforce, as the company believes that the diverse contributions and perceptions of different people progressively help the company find new and sustainable solutions in the health network.
Job Openings at Eurofarma
For those interested in being part of Eurofarma’s team, simply register for one of the processes the company offers through the website.


Be the first to react!